A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) to counteract soman-induced neurotoxicity in rats.

Source:http://linkedlifedata.com/resource/pubmed/id/17454028

Download in:

View as

General Info

PMID
17454028